Hearing aid oligopoly in the U.S. market (dominated by five companies) blocked FDA deregulation of over-the-counter hearing aids for years, but when the Biden administration finally allowed OTC hearing aids, it became a life-changing product for millions of Americans, demonstrating how concentrated power prevents beneficial innovations.